Houston, TX 的 重度憂鬱症 臨床試驗
16 項針對 重度憂鬱症 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
招募中2 期
- Baylor College of Medicine, Houston
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
招募中3 期
- Brain Health Consultants and TMS Center, Houston
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
招募中3 期
- DM Clinical Research, Houston
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
招募中3 期
- John S Dunn Behavioral Sciences Center at UTHealth Houston, Houston
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- Baylor College of Medicine, Houston
- Houston Clinical Trials LLC, Bellaire · 距離 7 英里
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Houston
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
招募中1 期歡迎健康志工
- Wells Medicine, Houston
- Texas A&M (Houston Methodist Hospital Location), Houston
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
招募中
- CHI St. Luke's Health Baylor College of Medicine Med. Ctr, Houston
- The Methodist Hospital, Houston
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
招募中2 期
- Elevate Synapsis, LLC, Atascocita · 距離 20 英里
- Synapsis Bio, Atascocita · 距離 20 英里
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
招募中3 期
- Clinical Research Site, Houston
- Clinical Research Site, Bellaire · 距離 7 英里
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Houston
- Neurocrine Clinical Site, Bellaire · 距離 7 英里
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Bellaire · 距離 7 英里
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Houston Clinical Trials - Bellaire /ID# 277551, Bellaire · 距離 7 英里
Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
招募中
- Houston Center For Advanced Psychiatric Treatment, Houston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Houston
Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
招募中歡迎健康志工
- Michael E. DeBakey VA Medical Center, Houston
- The University of Texas health Science Center at Houston, Houston
其他城市的 重度憂鬱症 試驗
- New York City, NY36 項研究
- Boston, MA31 項研究
- Atlanta, GA25 項研究
- Philadelphia, PA23 項研究
- Orlando, FL19 項研究
- Miami, FL18 項研究
- Chicago, IL17 項研究
- Tampa, FL17 項研究
- San Diego, CA16 項研究
- Little Rock, AR14 項研究
- Austin, TX13 項研究
- Las Vegas, NV13 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。